Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Suresh Babu

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Current Opinion in Molecular Therapeutics|July 23, 2003
Technology evaluation: mepolizumab, GlaxoSmithKlineGnanasegaram Gnanakumaran, K Suresh Babu
Hospital Medicine (London, England : 1998)|September 6, 2002
The role of anti-IgE therapies in the treatment of asthmaK Suresh Babu, Stephen T Holgate
BMJ (Clinical Research Ed.)|January 25, 2003
Non-invasive ventilation in chronic obstructive pulmonary diseaseK Suresh Babu, Anoop J Chauhan
The Indian Journal of Chest Diseases & Allied Sciences|May 25, 2002
Newer therapies for asthma: a focus on anti-IgEK Suresh Babu, Stephen T Holgate
Therapeutic Advances in Respiratory Disease|March 11, 2015
Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary diseaseK Suresh Babu, Jaymin B Morjaria
Paediatric Respiratory Reviews|March 5, 2003
The role of allergy in the development of airway inflammation in childrenK Suresh Babu, S Hasan Arshad
Clinics in Chest Medicine|April 6, 2004
Drug-induced airway diseasesK Suresh Babu, Benjamin G Marshall
British Journal of Clinical Pharmacology|March 18, 2008
Absence of respiratory effects with ivabradine in patients with asthmaK Suresh Babu, Frantisek Gadzik, Stephen T Holgate
Respiratory Medicine|March 26, 2013
Role of long term antibiotics in chronic respiratory diseasesK Suresh Babu, J Kastelik, J B Morjaria
Expert Opinion on Biological Therapy|March 23, 2013
Anti-IgE--emerging opportunities for OmalizumabK Suresh Babu, Riccardo Polosa, Jaymin B Morjaria
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Current Opinion in Molecular Therapeutics|July 23, 2003
Technology evaluation: mepolizumab, GlaxoSmithKlineGnanasegaram Gnanakumaran, K Suresh Babu
Hospital Medicine (London, England : 1998)|September 6, 2002
The role of anti-IgE therapies in the treatment of asthmaK Suresh Babu, Stephen T Holgate
BMJ (Clinical Research Ed.)|January 25, 2003
Non-invasive ventilation in chronic obstructive pulmonary diseaseK Suresh Babu, Anoop J Chauhan
The Indian Journal of Chest Diseases & Allied Sciences|May 25, 2002
Newer therapies for asthma: a focus on anti-IgEK Suresh Babu, Stephen T Holgate
Therapeutic Advances in Respiratory Disease|March 11, 2015
Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary diseaseK Suresh Babu, Jaymin B Morjaria
Paediatric Respiratory Reviews|March 5, 2003
The role of allergy in the development of airway inflammation in childrenK Suresh Babu, S Hasan Arshad
Clinics in Chest Medicine|April 6, 2004
Drug-induced airway diseasesK Suresh Babu, Benjamin G Marshall
British Journal of Clinical Pharmacology|March 18, 2008
Absence of respiratory effects with ivabradine in patients with asthmaK Suresh Babu, Frantisek Gadzik, Stephen T Holgate
Respiratory Medicine|March 26, 2013
Role of long term antibiotics in chronic respiratory diseasesK Suresh Babu, J Kastelik, J B Morjaria
Expert Opinion on Biological Therapy|March 23, 2013
Anti-IgE--emerging opportunities for OmalizumabK Suresh Babu, Riccardo Polosa, Jaymin B Morjaria
Pageof 11